Molecular targets in cancer therapy

Shivaani Kummar, James H. Doroshow

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


24th EORTC-NCI-AACR Symposium on 'Molecular Targets and Cancer Therapeutics' 6-9 November 2012, Dublin, Ireland The EORTC-NCI-AACR Symposium is an annual meeting, jointly hosted by the European Organization for Research and Treatment of Cancer, the US National Cancer Institute and the American Association for Cancer Research, to encourage exchange of information, dialogue and collaboration between investigators from the US, Europe and the world over regarding the development of novel cancer therapeutics. This meeting is hosted on alternate years in the US and Europe. This year's symposium, held in Dublin, Ireland, focused on the identification of novel targets, strategies for biomarker development and trial designs to expedite development of new therapies and improve patient selection. With over 30 oral presentations, more than 600 poster presentations and over 2000 participants, the meeting covered all the major aspects of oncology drug development, including the integration of newer platforms for the development of biomarkers.

Original languageEnglish (US)
Pages (from-to)267-269
Number of pages3
JournalExpert review of anticancer therapy
Issue number3
StatePublished - Mar 2013
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)


Dive into the research topics of 'Molecular targets in cancer therapy'. Together they form a unique fingerprint.

Cite this